Show simple item record

dc.contributor.authorSnelling, Thomas
dc.contributor.authorWaddington, C.
dc.date.accessioned2017-08-24T02:19:53Z
dc.date.available2017-08-24T02:19:53Z
dc.date.created2017-08-23T07:21:45Z
dc.date.issued2015
dc.identifier.citationSnelling, T. and Waddington, C. 2015. Whither pertussis?. Expert Review of Anti-Infective Therapy. 13 (2): pp. 145-148.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/55671
dc.identifier.doi10.1586/14787210.2015.986462
dc.description.abstract

© 2015 Informa UK, Ltd. Several lines of evidence suggest that pertussis disease will continue to rise in countries which have switched to acellular vaccines. While maternal vaccination is promising as a mitigating strategy it is unlikely to replace the need for a better vaccine. In the absence of a clear alternative, a return to using whole cell vaccines, at least in part, should not be dismissed as an option without contemporary studies of feasibility and acceptability.

dc.publisherExpert Reviews Ltd.
dc.titleWhither pertussis?
dc.typeJournal Article
dcterms.source.volume13
dcterms.source.number2
dcterms.source.startPage145
dcterms.source.endPage148
dcterms.source.issn1478-7210
dcterms.source.titleExpert Review of Anti-Infective Therapy
curtin.departmentSchool of Public Health
curtin.accessStatusOpen access via publisher


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record